Trident Lifeline Ltd's step-down subsidiary T-Med Biovation ceased to be a subsidiary effective March 27, 2025, following a disinvestment by its parent company, Trident Mediquip, which sold its shares for Rs. 99,990 to Mr. Hardik Desai, a promoter of Trident Lifeline.